$1.17
-0.03-2.5%
Last update: Nov 2, 3:57 PM

Wall Street analyst price targets and consensus rating for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI).
Price Target Range —
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months